Replies to post #39499 on Anavex Life Sciences Corp (AVXL)

[stealthways]

Parkinsons: any combo drugs possibilities?
Anyone familiar enough with Parkinsons to know what the drug landscape is in Parkinsons, and will they be testing 274 in combination, for synergy, with SOC Parkinsons drugs, in the just started MJFF preclinical trials for Parkinsons?

[TrueTrades]

I agree. The partner would likely be BP-enough to develop the compound across all indications, and would have rights as-such.

Could also explain a rapid progression of A2-73 in EP. BP might want to run with the blanket CNSD treatment thingy.

And all that could be just to set us up for 3-71. It won't be waiting forever, either.
§AVXL

[stealthways]

Thats is why I was asking about Parkinsos, because it looks like both AD and Epilipsey will be combo treatments, and if Parkinsons is also, then there would be three combo treatments which would eliminate the risk of "off label " sales, and make it easier to licence them separately.... If only Epilepsy and AD were combos, and if necessary Parkinsons was with straight 273 ...even with this structure, you could still licence the three separately to different BP, with minimal risks of off label sales .... as most would go for the convenience and stronger results of the combo vs purchasing 273 off label on Parkinsosn, for AD and Epilepsy...JMHO